EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings

Michihiko Goto iD, Shungo Imai iD, Hyunkeun Cho iD, James A Merchant, Matthew Bidwell Goetz iD, Eli N Perencevich iD, Bruce Alexander, Qianyi Shi iD, Andrea Holcombe, Daniel J Livorsi iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Michihiko Goto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Benchmarking, Antimicrobial Stewardship, Anti-Bacterial Agents, Drug Utilization. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HSRD VA, US Department of Veterans Affairs, VA Office of Research & Development, Health Systems Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inpatient antimicrobial stewardship programs (ASPs) promote avoiding unnecessary initiation, excessively long duration, and overly broad-spectrum selection of antimicrobials, but currently available metrics do not adequately reflect or distinguish these 3 components. We aimed to develop a novel framework that captures them while providing information specific to each, based on days of antimicrobial spectrum coverage (DASC) and length of therapy (LOT).

Methods

We developed a 3-level conditional modeling framework to extract hospital-level variability, risk-adjusted for 3 components (initiation, duration, and spectrum). This was applied to data from 118 Veterans Health Administration (VHA) hospitals, with models built on 2022–2023 data and validated with 2024 data. Patient demographics, intensive care status, admitting specialty, 86 comorbidities, and 224 procedure categories were considered candidate variables for risk adjustment. Overall hospital performance was evaluated using a composite metric that integrated 3 components (“S3 [start, stop, select] Metric”) and was visualized in a radar chart for each hospital.

Results

The cohort included 727 958 unique patients with 9 363 922 days present. Hospital-level usage ranged widely (DASC per 1000 DP: 1311–5275 [interquartile range (IQR): 2738–3563]; LOT per 1000 DP: 132.2–517.6 [IQR: 301.0–367.5]). Risk-adjustment models included 116 variables for initiation, 77 for duration, and 91 for spectrum components. S3 metrics ranged from 0.703 to 1.572 (IQR: 0.906–1.086). A 3-component evaluation could provide specific information on each hospital's usage patterns.

Conclusions

We propose a DASC-LOT framework and S3 metric to assess ASP practices in initiation, duration, and spectrum separately while providing overall composite benchmarking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenchmarkingAntimicrobial StewardshipAnti-Bacterial AgentsDrug UtilizationHumansInpatientsFemaleMaleMiddle AgedUnited StatesAgedHospitals, VeteransHospitalsDuration of Therapy

Stichwörter der Autor:innen

antimicrobial stewardshipbenchmarkinginpatient antimicrobial usemathematical frameworkrisk-adjustment

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa, USA.
  • Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
  • Department of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
  • Division of Biostatistics and Bioinformatics, Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.
  • Infectious Diseases Section, VA Greater Los Angeles Health Care System, Los Angeles, California, USA.
  • Department of Internal Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Michihiko Goto, Shungo Imai, Hyunkeun Cho, Matthew Bidwell Goetz, Eli N Perencevich, Qianyi Shi, Daniel J Livorsi

Förderung

  • HSRD VA
  • US Department of Veterans Affairs
  • VA Office of Research & Development, Health Systems Research

Zitieren

APA

Goto, M., Imai, S., Cho, H., Merchant, J. A., Bidwell Goetz, M., Perencevich, E. N., Alexander, B., Shi, Q., Holcombe, A., & Livorsi, D. J. (2026). DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag389

Vancouver

Goto M, Imai S, Cho H, Merchant JA, Bidwell Goetz M, Perencevich EN, et al. DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag389

BibTeX
@article{Goto2026,
  author = {Goto, Michihiko and Imai, Shungo and Cho, Hyunkeun and Merchant, James A and Bidwell Goetz, Matthew and Perencevich, Eli N and Alexander, Bruce and Shi, Qianyi and Holcombe, Andrea and Livorsi, Daniel J},
  title = {DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag389}
}
Kostenlos starten →